Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51824 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL2700400 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL4620826 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL5560221 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL3589695 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL6272191 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL5273177 | 1.00 | SLC6A2 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| Methyl Alcohol SCHEMBL8766906 | 0.95 | EPHX1 (0.43) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL9147278 | 0.88 | CYP2C19 (0.48) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 | |
| SCHEMBL4158886 | 0.88 | PTAFR (0.37) | SLC6A2ADRA1AHTR2BSLC6A3EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217769-B | Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina | 华南理工大学 | 2023-04-21 | — | — | CN | claimed |
| CN-111217769-B | Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina | 华南理工大学 | 2023-04-21 | — | — | CN | disclosed |
| WO-2021108683-A1 | COVALENT RAS INHIBITORS AND USES THEREOF | Revolution Medicines, Inc. (US) | 2021-06-03 | — | — | WO | disclosed |
| CN-111217769-A | Method for synthesizing epoxy compound by catalyzing olefin epoxidation through nano aluminum oxide | 华南理工大学 | 2020-06-02 | — | — | CN | disclosed |
| EP-1849778-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE PROCESS, AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-8410295-B2 | Method for production of optically active epoxy compound, and complex used therefor and process for producing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2013-04-02 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8163941-B2 | Reacting an unsaturated compound with oxidier in presence of a oxidation catalyst | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-24 | — | — | US | disclosed |
| US-8163941-B2 | Reacting an unsaturated compound with oxidier in presence of a oxidation catalyst | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1683791-B1 | Process for the epoxidation of olefins with hydrogen peroxide by ruthenium complex catalysed reaction | SALTIGO GMBH (DE) | 2008-04-02 | — | — | EP | disclosed |
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-03-20 | — | — | US | disclosed |
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-03-20 | — | — | US | disclosed |
| EP-1849778-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY COMPOUND, COMPLEX FOR USE IN THE PROCESS, AND PROCESS FOR PRODUCING THE SAME | Japan Science and Technology Agency (JP) | 2007-10-31 | — | — | EP | disclosed |
| CN-1817871-A | Process for the ruthenium-catalyzed epoxidation of olefins with the aid of hydrogen peroxide | LANXESS DEUTSCHLAND GMBH (DE) | 2006-08-16 | — | — | CN | disclosed |
| EP-1683791-A1 | Process for the epoxidation of olefins with hydrogen peroxide by ruthenium complex catalysed reaction | Lanxess Deutschland GmbH (DE) | 2006-07-26 | — | — | EP | disclosed |
| US-20060161011-A1 | Process for the ruthenium-catalysed epoxidation of olefins by means of hydrogen peroxide | LANXESS DEUTSCHLAND GMBH (DE) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071099-A1 | Method for Production of Optically Active Epoxy Compound, and Complex Used Therefor and Process for Producing the Same | EPRS1, PPOX, POR | SLC6A2 4731/4885ADRA1A 2871/4885HTR2B 3650/4885 |
| US-20060161011-A1 | Process for the ruthenium-catalysed epoxidation of olefins by means of hydrogen peroxide | PPOX, HAO2, GPX4 | SLC6A2 3841/4885ADRA1A 2158/4885HTR2B 2013/4885 |
| US-20120178954-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE EPOXY COMPOUND, AND COMPLEX USED THEREFOR AND PROCESS FOR PRODUCING THE SAME | CYP4F11, CYP51A1, COASY | SLC6A2 4821/4885ADRA1A 3448/4885HTR2B 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.